Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

A Folate Receptor-α–Specific Ligand That Targets Cancer Tissue and Not Sites of Inflammation

Balasubramanian Vaitilingam, Venkatesh Chelvam, Sumith A. Kularatne, Scott Poh, Wilfredo Ayala-Lopez and Philip S. Low
Journal of Nuclear Medicine July 2012, 53 (7) 1127-1134; DOI: https://doi.org/10.2967/jnumed.111.099390
Balasubramanian Vaitilingam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venkatesh Chelvam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumith A. Kularatne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Poh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilfredo Ayala-Lopez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip S. Low
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 53 no. 7 1127-1134
DOI 
https://doi.org/10.2967/jnumed.111.099390
PubMed 
22693311

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 11, 2011
  • Accepted for publication March 14, 2012
  • Published online July 2, 2012.

Article Versions

  • previous version (June 12, 2012 - 05:21).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2012 by the Society of Nuclear Medicine, Inc.

Author Information

  1. Balasubramanian Vaitilingam,
  2. Venkatesh Chelvam,
  3. Sumith A. Kularatne,
  4. Scott Poh,
  5. Wilfredo Ayala-Lopez and
  6. Philip S. Low
  1. Department of Chemistry, Purdue University, West Lafayette, Indiana
  1. For correspondence or reprints contact: Philip S. Low, Department of Chemistry, Purdue University, 560 Oval Dr., West Lafayette, IN 47907. E-mail: plow{at}purdue.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 32 Citations
  • 34 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Principles in the design of ligand-targeted cancer therapeutics and imaging agents
    Madduri Srinivasarao, Chris V. Galliford, Philip S. Low
    Nature Reviews Drug Discovery 2015 14 3
  • Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex
    Yan Tie, Heng Zheng, Zhiyao He, Jingyun Yang, Bin Shao, Li Liu, Min Luo, Xia Yuan, Yu Liu, Xiangxian Zhang, Hongyi Li, Min Wu, Xiawei Wei
    Signal Transduction and Targeted Therapy 2020 5 1
  • Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment
    Ayelet David
    Advanced Drug Delivery Reviews 2017 119
  • Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
    Peng Liu, Caifang Gao, Hongguo Chen, Chi Teng Vong, Xu Wu, Xudong Tang, Shengpeng Wang, Yitao Wang
    Acta Pharmaceutica Sinica B 2021 11 9
  • Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures
    Duy Luong, Prashant Kesharwani, Bryan A. Killinger, Anna Moszczynska, Fazlul H. Sarkar, Subhash Padhye, Arun K. Rishi, Arun K. Iyer
    Journal of Colloid and Interface Science 2016 484
  • Imaging the Folate Receptor on Cancer Cells with 99mTc-Etarfolatide: Properties, Clinical Use, and Future Potential of Folate Receptor Imaging
    Alan H. Maurer, Philip Elsinga, Stefano Fanti, Binh Nguyen, Wim J.G. Oyen, Wolfgang A. Weber
    Journal of Nuclear Medicine 2014 55 5
  • Platinum folate nanoparticles toxicity: Cancer vs. normal cells
    Tatsiana Mironava, Marcia Simon, Miriam H. Rafailovich, Basil Rigas
    Toxicology in Vitro 2013 27 2
  • Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach
    Abhilash Rana, Seema Bhatnagar
    Bioorganic Chemistry 2021 112
  • Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases
    Scott Poh, Venkatesh Chelvam, Wilfredo Ayala-López, Karson S. Putt, Philip S. Low
    Nanomedicine: Nanotechnology, Biology and Medicine 2018 14 3
  • Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
    Cristina Martín-Sabroso, Ana Isabel Torres-Suárez, Mario Alonso-González, Ana Fernández-Carballido, Ana Isabel Fraguas-Sánchez
    Pharmaceutics 2021 14 1

Article usage

Article usage: June 2012 to April 2025

AbstractFullPdf
Jun 2012330060
Jul 20127872792
Aug 20122603049
Sep 20121992939
Oct 20121462735
Nov 20121372627
Dec 20121141724
Jan 2013924052
Feb 2013696447
Mar 2013813469
Apr 2013754943
May 2013974954
Jun 2013504233
Jul 2013283840
Aug 2013423539
Sep 2013233536
Oct 2013363438
Nov 2013163744
Dec 2013392132
Jan 2014216059
Feb 2014273738
Mar 2014425348
Apr 2014343882
May 2014364947
Jun 2014334137
Jul 2014172927
Aug 2014142719
Sep 2014515431
Oct 2014335750
Nov 2014456439
Dec 2014242626
Jan 2015203625
Feb 2015193326
Mar 2015303320
Apr 2015222620
May 2015402214
Jun 2015122514
Jul 2015213129
Aug 201515209
Sep 2015233017
Oct 2015131911
Nov 2015472521
Dec 2015552211
Jan 2016503028
Feb 2016473331
Mar 2016252322
Apr 2016213216
May 2016382017
Jun 2016152825
Jul 2016273831
Aug 2016152426
Sep 201618279
Oct 2016152424
Nov 2016241822
Dec 2016121711
Jan 2017252316
Feb 2017111814
Mar 2017232720
Apr 201718128
May 2017131917
Jun 2017152217
Jul 20171188
Aug 201752719
Sep 201791923
Oct 2017202014
Nov 2017142912
Dec 20177139
Jan 20186119
Feb 201816198
Mar 2018192819
Apr 2018252411
May 201811206
Jun 201813209
Jul 2018112411
Aug 201817104
Sep 2018151911
Oct 2018123210
Nov 2018172912
Dec 20187303
Jan 2019192713
Feb 2019232314
Mar 2019463415
Apr 2019352825
May 201981010
Jun 201916519
Jul 201913137
Aug 201918417
Sep 20199710
Oct 2019181417
Nov 201913719
Dec 20191519
Jan 2020241212
Feb 202010717
Mar 2020151516
Apr 2020131321
May 202081129
Jun 202011917
Jul 2020516
Aug 2020121321
Sep 2020191117
Oct 202016410
Nov 202013617
Dec 202013610
Jan 202142011
Feb 202191510
Mar 202165525
Apr 202144724
May 202193118
Jun 20215127
Jul 202154023
Aug 202182120
Sep 202162523
Oct 202181933
Nov 202161822
Dec 2021132823
Jan 202241810
Feb 202242019
Mar 202211713
Apr 202272315
May 202261624
Jun 202272215
Jul 202253111
Aug 202221614
Sep 202261921
Oct 202222015
Nov 202262412
Dec 20224259
Jan 202332917
Feb 202342813
Mar 202322113
Apr 202362515
May 202372115
Jun 20235209
Jul 20237249
Aug 202331617
Sep 202372410
Oct 202373013
Nov 202371917
Dec 202342714
Jan 2024133316
Feb 202452217
Mar 2024112242
Apr 202468625
May 202414818
Jun 2024106111
Jul 20241113422
Aug 2024611917
Sep 202493213
Oct 202462613
Nov 2024103217
Dec 2024103623
Jan 202545313
Feb 2025127215
Mar 202574424
Apr 202594931
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (7)
Journal of Nuclear Medicine
Vol. 53, Issue 7
July 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Folate Receptor-α–Specific Ligand That Targets Cancer Tissue and Not Sites of Inflammation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A Folate Receptor-α–Specific Ligand That Targets Cancer Tissue and Not Sites of Inflammation
Balasubramanian Vaitilingam, Venkatesh Chelvam, Sumith A. Kularatne, Scott Poh, Wilfredo Ayala-Lopez, Philip S. Low
Journal of Nuclear Medicine Jul 2012, 53 (7) 1127-1134; DOI: 10.2967/jnumed.111.099390

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Folate Receptor-α–Specific Ligand That Targets Cancer Tissue and Not Sites of Inflammation
Balasubramanian Vaitilingam, Venkatesh Chelvam, Sumith A. Kularatne, Scott Poh, Wilfredo Ayala-Lopez, Philip S. Low
Journal of Nuclear Medicine Jul 2012, 53 (7) 1127-1134; DOI: 10.2967/jnumed.111.099390
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • A deep learning approach for the discovery of tumor-targeting small organic ligands from DNA-Encoded Chemical Libraries
  • Identification of a PET Radiotracer for Imaging of the Folate Receptor-{alpha}: A Potential Tool to Select Patients for Targeted Tumor Therapy
  • Evaluation of a Nonpeptidic Ligand for Imaging of Cholecystokinin 2 Receptor-Expressing Cancers
  • Imaging the Folate Receptor on Cancer Cells with 99mTc-Etarfolatide: Properties, Clinical Use, and Future Potential of Folate Receptor Imaging
  • Google Scholar

More in this TOC Section

  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire